Press Room

Statement of Christopher W. Hansen, President of the American Cancer Society Cancer Action Network (ACS CAN)

States have slashed funding for programs to reduce tobacco use by 12 percent in the past year and by 36 percent over the past four years, threatening the nation 's progress against tobacco.

WASHINGTON -- The Food and Drug Administration (FDA) announced today that it has revoked its approval of Avastin for metastatic breast cancer after concluding that the drug "has not been shown to be safe and effective for that use." The drug will remain an approved treatment for certain types of

Statement of the American Cancer Society, American Cancer Society Cancer Action Network, American Diabetes Association and American Heart Association

WASHINGTON, D.C. – November 7, 2011 – “Today’s ruling by a federal judge blocking the implementation of new graphic cigarette warning labels is bad for public health. The ruling in a lawsuit the tobacco industry filed against the U.S. Food and Drug Administration (FDA) in the U.S.

In an effort to make cancer a national priority with lawmakers, the American Cancer Society Cancer Action Network (ACS CAN) is releasing its second-ever national television ad to ask Congress to remember the countless lives lost to cancer and the nearly 12 million cancer survivors living in America today when making decisions to address the budget deficit.

WASHINGTON -- October 31, 2011 -- "The presidential executive order issued today is an essential step to address the growing drug shortage crisis, which is denying people with cancer access to the lifesaving medications they need.

The American Cancer Society Cancer Action Network today filed comments with the Centers for Medicare and Medicaid Services on the proposed rule on Medicaid eligibility under the Affordable Care Act.

The American Cancer Society Cancer Action Network today filed comments with the Internal Revenue Service on the proposed rule on health premium subsidies under the Affordable Care Act.

Today the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), submitted comments to HHS and the FDA in response to the proposed rule to modify the Common Rule, which governs the treatment of human subjects in clinical trials funded by m